首页> 外文OA文献 >Changes in identification of Her2 status according to 2018 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing: A real-world study based on consecutive hospital cohort of patients with Her2 IHC 2+ in China (2007-2017)
【2h】

Changes in identification of Her2 status according to 2018 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing: A real-world study based on consecutive hospital cohort of patients with Her2 IHC 2+ in China (2007-2017)

机译:根据2018年美国病理学家/美国临床肿瘤学会(CAP / ASCO)指南,人表皮生长因子受体2(HER2)荧光原位杂交(鱼类)测试的指南建议:真实世界研究基于中国连续医院患者的中国2+患者(2007-2017)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号